Free-Energy Profiles of Membrane Insertion of the M2 Transmembrane Peptide from Influenza A Virus  by Yeh, In-Chul et al.
Free-Energy Proﬁles of Membrane Insertion of the M2 Transmembrane
Peptide from Inﬂuenza A Virus
In-Chul Yeh,* Mark A. Olson,y Michael S. Lee,*yz and Anders Wallqvist*
*Biotechnology High Performance Computing Software Applications Institute, Telemedicine and Advanced Technology Research Center, U.S.
Army Medical Research and Materiel Command, yDepartment of Cell Biology and Biochemistry, U.S. Army Medical Research Institute of
Infectious Diseases, Fort Detrick, Maryland; and zComputational and Information Sciences Directorate, U.S. Army Research Laboratory,
Aberdeen Proving Ground, Maryland
ABSTRACT The insertion of the M2 transmembrane peptide from inﬂuenza A virus into a membrane has been studied with
molecular-dynamics simulations. This system is modeled by an atomically detailed peptide interacting with a continuum
representation of a membrane bilayer in aqueous solution. We performed replica-exchange molecular-dynamics simulations
with umbrella-sampling techniques to characterize the probability distribution and conformation preference of the peptide in the
solution, at themembrane interface, and in themembrane. Theminimum in the calculated free-energy surface of peptide insertion
corresponds to a fully inserted, helical peptide spanning the membrane. The free-energy proﬁle also shows that there is a
signiﬁcant barrier for the peptide to enter into this minimum in a nonhelical conformation. The sequence of the peptide is such that
hydrophilic amino acid residues at the ends of the otherwise primarily hydrophobic peptide create a trapped, U-shaped conformation
with thehydrophilic residuesassociatedwith theaqueousphaseand thehydrophobic residuesembedded in themembrane.Analysis
of the free energy shows that the barrier to insertion is largely enthalpic innature,whereas themembrane-spanningglobalminimum is
favored by entropy.
INTRODUCTION
The membrane insertion of proteins or peptides plays im-
portant roles in the mechanisms of viral infections, toxin
actions, and antimicrobial defense (1–3). The proper under-
standing of the mechanism of membrane insertion of peptides
and proteins forms the basis for developing therapeutic in-
terventions against bacterial and viral diseases (4,5). Since
typically the biologically active membrane-protein or peptide
functions only in the membrane environment, it is critical to
have an understanding of the membrane-bound structure.
However, despite signiﬁcant advances in experimental tech-
niques, only a limited number of membrane-protein struc-
tures have been experimentally determined (6). The same
experimental bottlenecks exist for small, membrane-bound
peptides. In addition, these peptides may also undergo large
conformational changes as part of the natural membrane-
insertion process. The structure and dynamics of membrane-
bound peptides have been partly investigated experimentally
by studying the insertion process of carefully designed small
synthetic peptides (7,8). For these types of studies, atomic-
detailed molecular dynamics (MD) simulation techniques
represent a valuable complementary methodology to inves-
tigate membrane-insertion of peptides (7). Thus, computer
simulations of membrane insertion of peptides have been
performed based on various models of membranes and pro-
teins ranging from full all-atom to coarse-grained models
with different levels of complexities (9–14).
There are two conﬂicting views on the mechanism of the
membrane insertion of peptides. One view is that the peptide
folds from an unstructured solvent state to a helix at the
membrane interface before the insertion. This avoids the high
energetic cost of desolvating the hydrogen bonds of the
peptide backbone in solution before the peptide associates
with the hydrophobic membrane (8). The other view holds
that the peptide will fold into a helix once inside the mem-
brane. This view is based on the results of a replica-exchange
MD (REMD) simulation (15) of a WALP16 synthetic model
peptide with explicit solvent and lipid-bilayer molecules,
where interface folding was not observed (11). This mode of
insertion and intramembrane folding was accompanied by a
large increase in the system entropy, which compensated for
the desolvation penalty (11). The membrane-insertion mech-
anism of the individual peptide may be dependent on its amino
acid sequence composition. However, it is not sufﬁcient to
predict the preferred membrane-insertion mechanism of the
individual peptide with the sequence data alone. A more ex-
tensive study with a diverse set of model peptides is needed to
reach a general conclusion on the mechanism of the membrane-
insertion process.
The M2 protein from inﬂuenza A virus is an essential
component of the viral envelope and forms a four-helix
bundle that exhibits a highly selective, pH-regulated, proton
ion-channel activity. The inﬂuenza A virus enters the infected
cell by endocytosis, and the interior of the virion must be
acidiﬁed while it is contained in the endosome as a prereq-
uisite for uncoating (release of genetic material to the cyto-
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plasm) (16). The proton channel formed by the M2 proteins
provides this acidiﬁcation function and is a potential thera-
peutic target (16). The M2 transmembrane peptide (M2-TMP)
is a truncated, synthetic peptide consisting of 25 amino acids
spanning the transmembrane domain of the original 97-amino-
acid M2 protein. The sequence of the M2-TMP is modeled as
SSDPLVVAASIIGILHLILWILDRL (17). This sequence is
effectively hydrophobic but contains hydrophilic anchoring
residues aspartate (D) and arginine (R) at the ends. Although
the truncated C- or N-terminal regions of the full-length M2
protein undoubtedly play important roles in the viral life
cycle, an ion channel activity was demonstrated with the
truncated M2-TMP (16,17). Recently, Stouffer et al. (18)
determined the high-resolution structure of the M2-TMP in
the presence of an amantadine-like inhibitors with x-ray
crystallography. In a companion article, Schnell and Chou
(19) used NMR techniques to determine the channel structure
of a slightly differently truncated version of the M2 protein.
Both structural assemblies share general structural features of
the M2 channel, such as a four-helix bundle state. However,
they also show signiﬁcant differences in structural details
related to the amantadine inhibition mechanism. Further
structural studies need to be carried out to resolve these dif-
ferences. Additionally, the M2-TMP four-helix bundle has
been studied by explicit atomistic MD simulations with
carefully chosen initial starting conﬁgurations to address is-
sues regarding structure and dynamics of the bundle in the
membrane (20–22). These studies did not address the sta-
bility of the four-helix bundle in the membrane interface. In
contrast, Bu et al. (23) used an implicit solvent/membrane
models to determine the optimal aggregation number of
helices in the membrane. Even though the M2-TMP tetramer
is more relevant to the biological function of the proton
channel, the M2-TMP monomer in the membrane environ-
ment has been studied experimentally (24) and computa-
tionally (12–14,25) to understand its structure and dynamics
in the absence of multimeric interactions. In these computa-
tional studies, the M2-TMP was either preinserted into the
membrane (12,25) or its backbone was ﬁxed to the helical
conﬁguration (13,14). However, missing from these studies
is the complete picture of the structural and energetic changes
undergone by the M2-TMP upon penetrating the membrane
from an aqueous solution.
Here, we report an extensive MD simulation study of the
insertion of the M2-TMP into a membrane. Different initial
conditions, replica exchange (15), and biased sampling
techniques with peptide position restraints (umbrella sam-
pling) have been used to ensure sampling of sufﬁcient con-
formations. This is done to avoid trapping the system in local
minima and to ensure that enough conformations of the M2-
TMP are sampled at all locations across the membrane in-
terface. Im and Brooks (9) contemplated the use of REMD
simulations combined with umbrella sampling to obtain
membrane-insertion free-energy peptide proﬁles. Recently,
MD simulations employing an extensive two-dimensional
(2D) biased-sampling technique with explicit solvent/mem-
brane representation were performed to study the thermo-
dynamic stability of a charged arginine in a transmembrane
helix (26,27). Similarly, the distribution of individual amino
acids in explicit solvent and lipid bilayer was studied using
umbrella sampling techniques (28,29). We ﬁnd that it is es-
sential to include both biased and REMD samplings to obtain
a reliable description of the membrane-insertion process for
the case of the M2-TMP. Indeed, all simulations except those
that employed the REMD simulation combined with the
umbrella sampling displayed deﬁciencies in the sampling of
the peptide conformation of the M2-TMP. To gain an un-
derstanding of the mechanism of membrane insertion of the
peptide, we calculated the potential of mean force (PMF)
(30), or the Helmholtz free energy, of the peptide insertion.
We ﬁnd that, at the global free-energy minimum, the M2-
TMP is a fully inserted helix with a tilt angle with respect to
the membrane normal closely matched to the experimentally
measured value. In addition, we ﬁnd that there is a signiﬁcant
free-energy barrier for the nonhelical peptide to insert into a
membrane from the aqueous phase commensurate with the
traditional view of peptide insertion. The constructed free-
energy surface also reveals an entropic barrier for the transfer
from the aqueous solution to the fully formed helix spanning
the membrane.
MATERIALS AND METHODS
MD simulations were performed with the CHARMM MD simulation pro-
gram version c31b2 (31). We used the all-atom CHARMM 22 force ﬁeld
with CMAPmodiﬁcation for proteins (32,33). The membrane and the water
solventwere represented by an implicit membrane/solvent model implemented
in the ‘‘Generalized Born with a simple SWitching’’ (GBSW) module of
CHARMM (25). The implicit membrane model has been successfully applied
to study membrane insertions of various model peptides (9). The membrane
thickness of 25 A˚, a membrane smoothing length of 5 A˚, and the sur-
face tension coefﬁcient of 0.04 kcal/(mol A˚2) were used to represent the
dimyristoylphosphatidylcholine (DMPC) membrane unless speciﬁed other-
wise (9,25). The DMPC was chosen because it is typically used in experi-
mental studies of the M2-TMP system (34).
Initial structures of the M2-TMP for simulations were taken from either a
fully extended conformation or an ideal a-helix structure as determined by
solid-state nuclear magnetic resonance (NMR) techniques (34). These
starting structures were optimized by energy minimization with a distance-
dependent dielectric constant of e ¼ 4r that included 50 steps of initial
steepest-descent minimization followed by minimization with the implicit
membrane model over 200 steps. During the minimization, Ca/Cb atoms of
all residues were restrained to their initial positions with a force constant of
0.5 kcal/mol, except for the last 100 steps. The resulting minimized con-
formations were used as starting structures of the subsequent MD simula-
tions.
A time step of 2 fs was used in the MD simulations. Langevin dynamics
with a friction coefﬁcient of 5.0 ps1 was used for the temperature control
(9). Covalent bonds between the heavy atoms and hydrogens were con-
strained by the SHAKE algorithm (35). Distances used for the onset of a
switching function for nonbonded interaction, the cutoff for nonbonded in-
teractions, and the cutoff for nonbonded list generationwere 20, 22, and 25 A˚,
respectively. Coordinates were saved at every 1 ps for further analysis. We
performed REMD simulations (15) by running the CHARMM MD simula-
tion programwith theMultiscaleModeling Tools for Structural Biology (36).
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Temperatures used for REMD simulations were 32 temperatures exponen-
tially spaced over the range from300 to 800Kunless speciﬁed otherwise. The
exchange of the conformations in neighboring temperatures was attempted at
every 500 time steps (1 ps) according to the Metropolis criterion.
In simulations with the peptide-position biasing, the Z-component of the
center-of-mass position of the peptide with respect to the membrane center
was restrained by the harmonic potential with a force constant of 2 kcal/(mol
A˚2) using the GEO command in the Miscellaneous Mean Field Potential
module in CHARMM. The Z-axis is deﬁned as an axis oriented parallel to
the membrane normal with the membrane center as its origin, so that the
membrane with the thickness of 25 A˚ used in our study is bound by two
planes at Z ¼ 612.5 A˚. The applied force constant was found to give
overlapping histograms of the peptide Z-positions for all neighboring
Z-position biased systems. The weighted histogram analysis method
(WHAM) (37) described by Gallicchio et al. (38) was used to remove biases
due to temperatures or peptide positions and obtain PMF or free-energy
proﬁles of membrane insertion of the peptide. The statistical uncertainties in
the WHAM analysis were also estimated by the procedure outlined in
Gallicchio et al. (38). We calculated the PMF as RTlogðPÞ; where P is a
probability distribution as a function of the root mean-square distance
(RMSD), the Z position of the peptide, or the tilt angle at temperature
Tobtained from the WHAM analysis, and R is the ideal gas constant in units
of kcal/mol/K. The RMSD between two structures is deﬁned as the square
root of the minimum average square distance between respective backbone
atoms of the two structures with respect to all rigid body rotations and
translations (39). The RMSD was calculated with respect to the a-helix
structure determined by solid-state NMR techniques (34) unless speciﬁed
otherwise. The tilt angle was deﬁned as an angle between the long axis of the
peptide, as determined from the inertia tensor, and the membrane normal.
The durations of the simulations performed in this study were as follows:
The REMD simulation of the M2-TMP in aqueous solution lasted 5 ns.
REMD simulations of the fully extended M2-TMP preinserted in the
membrane and placed outside the membrane lasted 30 and 40 ns, respec-
tively.We performed 81 5-nsMD simulations of theM2-TMP using a helical
starting conﬁguration with its center-of-mass Z-position restrained at loca-
tions ranging from Z ¼ 0 A˚ to 40 A˚ in 0.5-A˚ increment. For the 31 systems
restrained between Z ¼ 0 A˚ and 15 A˚, we performed additional 4-ns REMD
simulations. This was done to enhance sampling of the barrier regions of the
free energy.
The temperature ranges used for unrestrained REMD simulations of a
fully extended M2-TMP in the presence of the membrane were from 300 to
500 K when it was preinserted, and from 300 to 800 K when it was placed
outside the membrane. The average acceptance ratios for the replica ex-
change during the last 10 ns of production runs were 77% and 57% for the
narrower and wider temperature ranges, respectively. The numbers of round
trips of replicas from the lowest temperature to the highest and back were 138
with the average round-trip time of 3.4 ns for the 30-ns REMD run with the
preinserted M2-TMP, and 32 with the average round-trip time of 9.1 ns for
the 40-ns REMD run of the M2-TMP started outside the membrane. All
replicas were not distributed equally among the temperatures. However,
every replica visited each temperature at least 23 times with the preinserted
M2-TMP, and all the temperatures except for the lowest two were visited at
least three times by every replica when the M2-TMP was placed outside the
membrane.
RESULTS
We present our results in the following order: We ﬁrst report
on the solution structure of the M2-TMP using REMD sim-
ulations. This is followed by the results of REMD simula-
tions to characterize the M2-TMP in the presence of a
membrane. We then report on the calculation of the free-
energy surface of the M2-TMP across the membrane inter-
face using extensive REMD simulations combined with bi-
ased sampling techniques.
M2-TMP in aqueous solution
To understand the structural preferences of the M2-TMP in
aqueous solution, we performed an REMD simulation of the
peptide in the absence of a membrane. The water solvent was
described implicitly with the GBSW model. This simulation
was started from the helical conformation shown in Fig. 1 a
and lasted 4 ns. The distribution of RMSD of structures at the
room temperature of 300 K with respect to the initial helical
conformation is shown in Fig. 1 b. This was calculated by
performing theWHAM analysis on the data from the last 2 ns
of the simulation. Snapshots and the RMSD distribution of
the M2-TMP at room temperature shown in Fig. 1, a and b,
indicate that the initial helical structure of the M2-TMP de-
cays rapidly and is not present in any measurable quantity in
the solution phase. To examine the structures of the M2-TMP
in aqueous solution in more detail, we calculated the distri-
bution of all pairwise RMSD between 400 structures ran-
domly selected from the last 2 ns of the 300 K trajectory. This
distribution is shown in Fig. 1 c, and its lack of uniformity is
indicative of the presence of diverse solution structures. In
particular, the distribution has an isolated peak at a pairwise
RMSD of 0.7 A˚, indicating that there may be a set of dom-
inant structures. Indeed, it was found that 199 of the ran-
domly selected 400 structures belong to a set of structures
within a pairwise RMSD of 2 A˚. This set includes the last
conﬁguration shown in Fig. 1 a. In this set of structures, the
helicity is broken in the middle of the peptide sequence. The
structure of the M2-TMP at 3.625 ns in Fig. 1 a shows a
disruption of the helicity at a slightly different location of the
peptide chain and belongs to the second-largest cluster with
38 structures whose pairwise RMSD are within 2 A˚. How-
ever, there is a signiﬁcant population of structures (163 out of
400) that are not part of these two main conformational
groups, which indicates a diverse set of peptide conforma-
tions in solution. This is consistent with the experimental
observations that many a-helical membrane peptides can
exist in a variety of semi- or unstructured forms in aqueous
solutions (40,41).
M2-TMP in the presence of a membrane
We performed MD simulations of the M2-TMP in the pres-
ence of a membranewith different initial conditions. However,
we determined that simple applications of MD simulations at
constant temperatures are not adequate to properly and efﬁ-
ciently sample intramembrane folding or membrane insertion
of the M2-TMP. Therefore, we performed two REMD simu-
lations starting from the fully extended peptide conformation:
one preinserted perpendicularly into a membrane, and the
other placed parallel outside the membrane as shown in Fig.
2, a and b, respectively. In the REMD simulation of the
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preinserted M2-TMP, we employed 32 temperatures ranging
from 300 to 500 K and a membrane smoothing length of
0.6 A˚. The temperature range and the membrane smoothing
length were chosen to match those used in a previous REMD
simulation by Im et al. (25) of the preinserted M2-TMP.
Ulmschneider et al. (12) performed a replica-exchange Monte
Carlo simulation of the same system, but with a different
implicit membrane model. Our simulation lasted 30 ns, and
the last 10 ns of the simulation were used for the analysis. It
is important to note that extensive equilibrations are required
in REMD simulations to avoid simulation artifacts (42). The
PMF surface was constructed as a function of tilt angle and
the RMSD from the helical structure. This is shown in Fig.
3 a. Similarly, the PMF surface was also calculated as a
function of the Z-distance of peptide from the membrane
center and the RMSD from the helical structure, as shown in
Fig. 3 b. The most probable tilt angle in the PMF surface in
Fig. 3 a is consistent with the experimentally observed value
of 38 6 3 in the DMPC membrane (34). It corresponds to
the tilt angle needed to localize the charged groups of the
helix to the membrane interface. The tilt angle is also in
agreement with the 35 6 2 observed in the recently de-
termined crystal structure of the M2-TMP four-helix bundle
(18). The PMF surfaces in Fig. 3, a and b, and examination of
the conﬁgurations of the M2-TMP at the lowest temperature
show that REMD simulations of the preinserted peptide
converged to those of membrane-spanning helical confor-
mation (RMSD ¼ 0 A˚), consistent with results of previous
replica-exchange simulations (12,25).
In an attempt to simulate spontaneous membrane insertion
of the M2-TMP from the aqueous solution, we also per-
formed an REMD simulation of the M2-TMP initially placed
45 A˚ away from the center and parallel to the membrane in an
initially fully extended peptide conformation, as shown in
Fig. 2 b. In this REMD simulation, we employed 32 tem-
peratures ranging from 300 to 800 K and a membrane
smoothing length of 5.0 A˚. The same set of parameters was
used in REMD simulations of membrane insertions of other
peptides with the same implicit membrane model (9). The
simulation lasted 40 ns, and conﬁgurations from the last 10 ns
were used for the analysis. We calculated a PMF surface as a
function of the Z-position of the peptide and RMSD with
respect to the helical conformation using the WHAM anal-
FIGURE 1 (a) Snapshots of the M2 transmembrane peptide (M2-TMP)
(sequence: SSDPLVVAASIIGILHLILWILDRL) from the REMD simula-
tions in the implicit solvent at 300 K. The initial [time (t) ¼ 0 ns] helical
conformation corresponds to the experimentally determined structure. (b)
The RMSD distribution of the M2-TMP in aqueous solution without the
membrane obtained from the WHAM analysis on the last 2 ns of trajectories
from the REMD simulation. The RMSDs are calculated with respect to the
initial helical conformation. (c) The distribution of pairwise RMSD of 400
structures randomly selected from the last 2 ns of the 300-K trajectory. This
distribution was calculated by forming all possible pairs between the 400
structures and calculating the RMSD for each pair. Almost half of the
structures (199 out of 400) belonged to a cluster in which all members were
within an RMSD of 2 A˚ from each other. This set includes the last
conﬁguration of the M2-TMP at 4 ns shown in a. The second-largest cluster
(38 members) contains the conﬁguration of the M2-TMP at 3.625 ns, shown
in a.
FIGURE 2 Two different starting conﬁgurations of the fully extended
M2-TMP. (a) TheM2-TMP is preinsertedperpendicularly into themembrane.
(b) The M2-TMP is initially placed outside but parallel to the membrane
surface.
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ysis. The PMF surface along with the last conﬁguration of the
M2-TMP at the temperature of 300 K is shown in Fig. 3 c. In
this case, however, structures generated by the REMD sim-
ulation did not contain structures that were fully inserted into
the membrane (Z ¼ 0 A˚), as seen by the lack of any con-
formations in the lower part of the PMF surface in Fig. 3 c.
Instead, the REMD simulation generates bent conformations
where the middle section of the peptide is inserted into
membrane while the two end groups remain near the interface
outside the membrane core, as shown by the van der Waals
spheres at right in Fig. 3 c. This trapped conformation of the
M2-TMP resembles the ﬁnal solution structure shown Fig.
1 a with an RMSD of 3.5 A˚. Both structures share a common
motif of a U-shaped conformation even though the details
of the structures differ. However, U-shaped conformations
of the M2-TMP in the membrane interface and the solution
are thought to have different origins. The U-shaped con-
formation of M2-TMP in the solution may arise from the
interresidue hydrophobic interactions. The U-shaped con-
formation at the membrane interface is mainly due to the
partitioning of hydrophilic end groups and hydrophobic
groups between aqueous and membrane environments, re-
spectively. According to hydrophobicity scales developed by
Wimley and White (43) and more recently by Hessa et al.
(44,45), both N- and C-terminal ends of the M2-TMP contain
strongly hydrophilic residues Asp and Arg, whereas the
FIGURE 3 PMF surfaces at 300 K calculated from the
conformations generated by REMD simulations of the M2-
TMP. (a) PMF surface as a function of the RMSD and tilt
angle of the M2-TMP initially preinserted into the mem-
brane. (b) PMF surface as a function of the RMSD and
Z-position of M2-TMP initially preinserted into the mem-
brane. A membrane-spanning conﬁguration of the peptide
is shown in atomic detail at right. The hydrophilic residues
are drawn with atomic van der Waals spheres and are
shown located at both sides of the membrane. (c) PMF
surface as a function of the RMSD and Z-position of the
M2-TMP initially placed outside of the membrane at a
distance of 45 A˚ away from the membrane center. The
minimum of the PMF is set to 0 by normalizing the
probability distribution with the maximum probability.
Here, a representative, trapped peptide conformation is
shown with the hydrophilic residues at both ends of the
peptide at the interface and the hydrophobic middle resi-
dues solvated in the membrane core.
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middle section of the M2-TMP includes hydrophobic resi-
dues, e.g., Leu, Val, Ile, and Trp. Although these strong
hydrophilic amino acid residues may play important roles in
anchoring this peptide in speciﬁc position and tilt angle,
they also appear to present a signiﬁcant barrier to the full
membrane insertion of this peptide in the current implicit
membrane model. We also did not observe a spontaneous
peptide insertion in an REMD simulation with the different
smoothing parameter of 0.6 A˚ (results not shown). Our
observations on the lack of spontaneous insertion are thus
not strongly parameter dependent. A remaining question is
whether we can identify the global conformation minimum
from these two different peptide conformations shown in
Fig. 3. The results up to this point suggest that a simple
application of REMD simulation with temperature pertur-
bation is not sufﬁcient to overcome the problem of initial
condition dependency and determine the global minimum
structure of the peptide.
Free-energy REMD simulations with
peptide-position biasing
To avoid trapping the M2-TMP in local minima of the free-
energy surface and to sample peptide conformations at a
wider range of points across the membrane/water interface,
we performed MD simulations of the M2-TMP with its
center-of-mass Z-position restrained at multiple locations
across the membrane interface. These simulations were
started from the helical conformation based on the NMR
experimental structure. The peptide was initially oriented
parallel to the membrane interface. The center-of-mass
Z-position of the peptide was restrained at 81 points across
the membrane interface in intervals of 0.5 A˚ starting at the
center of the membrane (Z ¼ 0 A˚) and ending at Z ¼ 40 A˚.
Only the upper half of Z-positions (Z$ 0 A˚) was considered
because the peptide-membrane interaction is expected to be
symmetric with respect to the membrane center. These
MD simulations with peptide position restraints lasted 5 ns.
Analysis of these MD simulations revealed a lack of sam-
pling of peptide conformations characterized by the de-
pendency on initial conditions. Therefore, to ensure proper
samplings of peptide conformations of the M2-TMP across
the membrane interface, we performed additional 4-ns REMD
simulations starting from each of the restrained M2-TMP/
membrane systems after 5-ns MD simulations. REMD sim-
ulations were not extended to points past Z ¼ 15 A˚ since
peptide conformations beyond this distance are not relevant
to the membrane-insertion process. It is to be noted that
conformations of the M2-TMP in the limit of large Z were
sampled by the REMD simulation of the M2-TMP in aque-
ous solution as described above. The last 1 ns of REMD
simulation trajectory was used for the analysis. We removed
the biasing imposed by the Z-position restraints and calcu-
lated PMF surfaces as a function of Z-positions and RMSD
with theWHAM analysis. The calculated free-energy surface
in Fig. 4 a shows the relative free-energy change of each
conformation with respect to the distance from the membrane
center and the RMSD from the experimental helical confor-
mation. At near Z¼ 15 A˚, structures with large RMSD values
are dominant, in agreement with the solution structure shown
in Fig. 1 b. However, near the interface at Z¼ 10 A˚, small and
large RMSD values coexist with similar free energies. This
FIGURE 4 PMF at 300 K of the M2-TMP calculated from REMD simu-
lations combined with the center-of-mass Z-positional restraints. The peptide
center-of-mass Z-position is restrained at various locations extending from
the center of the membrane to the point where Z ¼ 15 A˚ at 0.5-A˚ intervals.
The ﬁnal PMF surface is pieced together from restrained simulations by the
WHAM analysis. (a) PMF surface as a function of the M2-TMP’s Z-position
and RMSD with respect to the experimental helical conformation. The
overall global minimum is seen as the dark red area in the lower left-hand
corner and corresponds to a helical conformation spanning the membrane
with the appropriate experimental tilt angle. (b) 1D energy proﬁles obtained
by averaging the 2D probability distributions over all RSMD values. The
PMF proﬁle as a function of the Z-position of the M2-TMP clearly shows the
overall hydrophobic attraction of the solvated peptide to the membrane, but
it also shows a barrier to full penetration into the membrane core. The
averaged potential energy (DUÞ proﬁle shows that the partially inserted
trapped peptide is stabilized by the enthalpic component outside the
membrane core, and that these states are more energetically favorable than
a fully inserted peptide at Z ¼ 0 A˚. The entropic contribution (TDS) to the
free-energy surface was calculated from the difference between the PMF and
the ensemble average potential energy (PMF DUÞ. This graph clearly
shows that the trapped states outside the membrane core are disfavored
whereas the fully inserted peptide (which is experimentally observed) is
favored. The statistical uncertainties in the PMF and the average potential
energy proﬁles are twice the standard deviation estimated by the WHAM
error analysis.
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surface shows that the global minimum conformation of the
peptide is that of a fully inserted helix, as indicated by the
favorable free-energy region at small RMSD near the mem-
brane center. However, the free-energy surface also shows
that there is a signiﬁcant barrier, exceeding 90 kcal/mol, for
the M2-TMP to fully insert into a membrane in a nonhelical
peptide conformation. Indeed, the surface indicates that con-
formations starting outside the membrane are funneled into a
secondary minimum corresponding to a set of nonhelical
conformations trapped outside the membrane core (Z ;7 A˚,
RMSD ;9 A˚). The PMF surface in Fig. 4 a also indicates
that there are considerable kinetic barriers between the two
conformations, i.e., the U-shaped-trapped and membrane-
spanning conformations. For example, a structural transfor-
mation of the peptide from a nonhelical conformation to a
near helical conformation at a peptide center-of-mass posi-
tion of Z;7 A˚ followed by membrane insertion is associated
with a free-energy barrier on the order of 50 kcal/mol. Fig. 4 a
also indicates that there are narrow, lower-energy paths be-
tween the two conformations with a free-energy barrier on
the order of 10 kcal/mol. However, these paths require spe-
ciﬁc peptide conformations at speciﬁc Z positions, and their
signiﬁcance may need to be checked with further simula-
tions. Since there is no clear ‘‘path’’ in this energy surface
between the two regions in the surface, the preceding REMD
simulations were never able to switch between the confor-
mations. The probability of traversing the barrier in a regular
MD simulation without the biased potential is thus negligi-
ble, and traditional non-free-energy simulations will always
show a strong dependence on the initial conformations.
To look at the overall changes in energies, we constructed
PMF proﬁles in only the Z-direction from the one-dimen-
sional (1D) probability distribution of the peptide Z-position
obtained by averaging the unbiased 2D probability distribu-
tion for all values of the RMSD coordinate. The free-energy
proﬁle along the Z axis with the estimated error from the
WHAM analysis in Fig. 4 b clearly identiﬁes a global mini-
mum at Z ¼ 0 A˚ and displays a shallow local minimum at
around Z ¼ 7 A˚. This local minimum is reﬂective of the
M2-TMP trapped outside the membrane core in a nonhelical
conformation where the hydrophobic middle part of the
peptide and the charged residues at the ends are attracted to
the membrane core and the water phase, respectively. As the
M2-TMP is further pushed in, the repulsion increases due to
the loss of water solvation of the charged residues, and an
effective free-energy barrier separating the global and local
minima is created. This barrier is centered at around Z¼ 5 A˚.
The magnitude of the barriers in the 2D free-energy proﬁle in
Fig. 4 a appears more pronounced because of the detailed
structural breakdown provided in the 2D proﬁle. Once the
peptide overcomes this barrier, it readily ﬁnds the global
minimum at the membrane center where the hydrophobic
middle and the charged residues at each end occupy the
membrane core and the hydrophilic solvent, respectively.
The potential energy proﬁle along the Z-axis in Fig. 4 b
shows that the overall minimum of the potential energy is
located at around Z¼ 7 A˚ instead of at the membrane center,
suggesting that the trapped conﬁguration is energetically
favorable. The fact that the fully inserted M2-TMP is at the
global minimum is due to entropic components in the free
energy. This is illustrated in Fig. 4 b, where we show the
difference between the PMF and the internal energy, i.e., the
entropic contribution (TDS) to the free energy. It is to be
noted that this estimate of the entropic contribution does
not include the contribution from the nonpolar solvation
energy in the implicit solvent/membranemodel. The U-shaped
trapped conformation of the M2-TMP is favored by enthalpy
but disfavored by entropy, whereas the membrane spanning
helical conformation is actually disfavored by enthalpy but
favored by entropy. The favorable entropic contribution to
the free energy was also observed in a simulation study of the
WALP16 peptide using an atomically explicit membrane
model (11).
DISCUSSION
In this study, we performed extensive MD simulations of the
M2-TMP at various positions across the membrane interface
to study the membrane-insertion process of an atomically
detailed peptide. The aqueous solution and the bilayer mem-
brane itself were treated in the continuum approximation using
a generalized Born model. To enhance samplings of peptide
conformational states beyond those trapped in local minima,
we performed REMD simulations with and without peptide
positional restraints. REMD simulations without peptide po-
sitional restraints were able to ﬁnd the experimental helical
conformation of the M2-TMP when it was preinserted, but
failed to show a spontaneous membrane insertion when the
peptide was initially placed outside the membrane. Only by
performing REMD simulations combined with peptide posi-
tional restraints were we able to identify the fully inserted
M2-TMP helix as the global minimum state in the free-energy
surface, which is in agreement with the experimental results.
These ﬁndings underscore the importance and difﬁculties of
sampling enough conformational states to obtain a meaning-
ful and statistically signiﬁcant free-energy surface from MD
simulations.
There have been conﬂicting notions regarding the mech-
anism of peptide membrane insertion. The central question is
whether the a-helix formation precedes the peptide insertion
into a membrane or not. In the broadly accepted model (8),
protein folding at the interface always precedes membrane
insertion of proteins. However, a recent REMD simulation
study (11) of membrane insertion of the WALP16 peptide
using explicit solvent/lipids indicates that the interfacial
folding is not required for bilayer insertion. The current re-
sult from the M2-TMP using an implicit membrane model
suggests that the peptide would have difﬁculty penetrating
the membrane in a nonhelical conformation due to a large
free-energy barrier. It is possible that peptides, such as the
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M2-TMP, that have strongly hydrophilic groups follow dif-
ferent membrane-insertion mechanisms than the WALP16
peptide. It is also possible that detailed interactions of the
peptide with explicit lipid headgroups and water molecules
may be important in the initial stages of the peptide insertion
to escape any trapped conformational state in local minima.
In recent simulation studies of a charged arginine side chain
in a transmembrane helix using an explicit atom representa-
tion of the lipid membrane and waters, it was shown that the
charged side chain is signiﬁcantly stabilized by favorable
interactions with water molecules and lipid headgroups
(26,27). It is suggested that the depolarization effects are
overestimated in implicit membrane models that do not ac-
count for the ﬂexibility of the membrane interface, and hence
the effective barriers to hydrophilic peptide penetration are
overestimated in such models (26,27,46). In the explicit atom
simulations, the ﬂuctuations of motions of lipids and water
can create vacancies that can facilitate the membrane inser-
tion of the peptide. However, performing fully atomistic
simulations and employing extensive sampling techniques
still remain a signiﬁcant challenge. The implicit membrane
model in conjunction with good sampling techniques can still
provide insights into the peptide membrane-insertion process
by capturing the gross physical features of the system. Im-
provements of the implicit membrane model with varying
local dielectric coefﬁcients across the membrane interface (47)
could be used to further improve the implicit representation.
Possible alternatives to either the costly explicit-membrane
model or simplistic implicit membrane representations are
various coarse-grained membrane models (48–52). Fine-tun-
ing of the implicit membrane model with the results from
simulations with explicit membrane/water would be highly
desirable (28). The formation of multimeric complexes may
also play an important role by facilitating self-solvation of
hydrophilic peptide groups in the hydrophobic membrane en-
vironment. Further experimental and computational studies
with a diverse set of peptides may be needed to arrive at any
deﬁnitive conclusion on the mechanisms of membrane inser-
tion of peptides. The results from this study of the membrane-
insertion mechanism demonstrate that careful analysis of the
simulations with proper samplings of conformational states is
needed to obtainmeaningful information from the simulations.
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